2. Introduction
Cipla Limited is an Indian
multinational pharmaceutical company,
headquartered in Mumbai, India.
It was founded by Khwaja Abdul
Hamied as 'The Chemical, Industrial
& Pharmaceutical Laboratories' in 1935.
portfolio in markets of India, South
Africa and North America, as well as key
regulated and emerging markets.
Cipla is ranked third largest pharma in
India with Revenue of US$ 2.5 billion in
2020.
3. • Breathefree is a public service initiative by Cipla
& a comprehensive patient support system for
patients with obstructive airway diseases.
• On World Asthama day Cipla Run Twitter hastag
Asthma ke liye #InhalersHainSahi
• bust some myths around asthma by posting
Awareness videos.
• Ayushman Khurana, Neena Gupta and Vikas
Khanna’s Candid take on experience with
asthma poted on twitter account.
• #AtoZofAsthma Under this hastag Best Doctors
from country Provide awareness about asthama
• Cipla is focusing on prostate gland disorder,
advertising its expertise in the area and targeting
50-plus males in the campaign to Create
Awareness
4. Cipla Partners with Priyanka Chopra
To raise awareness about asthma, along
with helping address its psychosocial
aspects including stigma
• one of the key contributing factors for patient anxiety,
delayed diagnosis, denial & limited disclosure of being
asthmatic and avoidance of inhaler use in public.
• As a part of a holistic multipronged campaign bring an
attitudinal change towards inhalation therapy as the
most effective for asthma management.
5. On Their twitter Handle to increase Awareness
about Covid.
• It’s not true that COVID-19 vaccines cause
infertility. According to the World Health
Organization, there's no vaccine that causes
infertility. Get vaccinated when your turn comes.
#CaringForLife
• To focus on #lunghealth and we can collaborate
to fight this threat and help India breathe free
During This Pandemic.
• For the WestBengal elections Cipla took an
initiative of ensuring the safety of everyone
involved. By Running Hashtag -Let’s keep up our
fight against COVID-19 by adhering to all the
hygiene practices. #HarHaathKeSaath
• As part of our initiative #WithOurHeroes, we
provided 20,000 hand Sanitiser packs to the
Mumbai Police and Brihanmumbai Electricity
Supply and Transport (BEST) authorities.
6. • The eco-system for pharmaceutical companies
drastically changed .
• The entire field force moved to a digital detailing
platform.
• Practical and strategic decision making is facilitated
through real-time information by Tools like advanced
analytics.
• The availability of e-detailing is slowly but surely
completely changing Cipla’s relationship with doctors,
and it is now easier to educate doctors about drugs and
get their insights on those being prescribed.
7. • Enabled Cipla’s sales force to Meaningful discussion in short facetime with the
doctor.
• CLM system automatically analyses a physician’s
• Personalised content that closely matches the physician’s interests
• Accompanying e-detailing software displays and manages visual aids such
• Drug maker is using the targeting power of digital media to create small patient
communities
• As a pharmaceutical company, Indian norms restrict an organization like Cipla to
advertise its products.
• Therefore, the company has been taking an interesting route, of not talking about its
offerings directly, but rather about some of the conditions that its products treats, in
order to raise awareness and educate consumers.
9. Insights &
Recommedations
India is often labeled as the ‘pharmacy of the world’, But with reliance
on API imports from China running to well over 60% for most drugs,
India’s claim to be a world leader in pharmaceuticals is heavily
compromised.
India is the largest provider of generic drugs globally. India has one of
the lowest manufacturing costs in the world – lower than that of the
U.S. and almost half of the cost in Europe.
The country plans to intensify the battle against the novel coronavirus,
Cipla Can Provide As much possible support to Govt.
Cipla should look up to and invest in biotechnology. India’s
biotechnology industry, comprising biopharmaceuticals, bio-services,
bio agriculture, bio-industry and bioinformatics is expected to grow at
an average rate of around 30% a year and reach $100 billion by 2025.
